Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 238, pseudogene (RN7SL238P) is a pseudogene that represents a nonfunctional, non-coding genomic remnant derived from the 7SL RNA gene family, which encodes the RNA component of the signal recognition particle (SRP) responsible for co-translational protein targeting to the endoplasmic reticulum[1][7][6]. Pseudogenes like RN7SL238P generally do not encode functional products and are not considered therapeutic targets. While some pseudogenes can be transcribed and may exert regulatory impacts via mechanisms such as acting as microRNA decoys or sources of small interfering RNAs, there is no evidence that RN7SL238P itself serves as a therapeutic target or has well-established biological or disease associations[4][7]. Its primary classification is that of a non-coding RNA pseudogene, and it shares homology with the RNA, 7SL, cytoplasmic 1 (RN7SL1) gene, the authentic functional SRP RNA gene[5][8]. Some pseudogenes are deregulated in cancer or neurodegeneration, but there is no evidence specific to RN7SL238P[7][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 238, pseudogene (RN7SL238P).